Home > Clinical Trials > Cancer Clinical Trial > Brain and Nervous System > A Randomized, Double-Blinded, Placebo-Controlled Phase II Study of (ERC1671/ GM-CSF / Cyclophosphamide) + Bevacizumab versus (Placebo Injection / Placebo pill) + Bevacizumab in the Treatment of Recurrent/Progressive, Bevacizumab Naïve Glioblastoma Multiforme and Gliosarcoma Patients (WHO Grade IV Malignant Gliomas)